By DA NANG Today / DA NANG Today
January 03, 2021, 11:16 [GMT+7]
In December 2020, Da Nang government granted certificates to 18 Da Nang-developed products for meeting One Commune-One Product (OCOP) standard.
Workers are seen busy at the ‘Ba Lieu Me’ manufacturing establishment in Cam Le District’s Hoa Tho Dong Ward
Of this, seven products were recognised for meeting 4-star standards under the so-called OCOP model, whilst the remainder met 3-star standards.
The OCOP model made its debut in 2008 in Viet Nam, following the model of Japan-initiated ‘One Village, One Product’ and Thailand-developed ‘One Town, One Product’.
It is an economic development programme for rural areas focusing on increasing internal power and values, which is also meant to help with Viet Nam s national target programme on upgrading rural areas.
By VNA / DA NANG Today
December 31, 2020, 08:36 [GMT+7]
Director of An Giang province’s Department of Public Security, Col. Dinh Van Noi, announced on December 30 that the department’s Investigation Security Agency has issued a decision to begin legal proceedings in a case of organising illegal entry into Viet Nam in the local district of An Phu on 24 December.
An area with a suspected Covid-19 case is sealed off (Illustrative photo: VNA)
Noi said that the investigation detected signs of criminal activity in the case, and decided to commence legal proceedings to expand investigations.
The province’s Department of Public Security is coordinating with the provincial Border Guard and An Phu district authorities in catching those that helped Covid-19 Patient 1,440 illegally enter Viet Nam.
By VNA / DA NANG Today
December 27, 2020, 10:07 [GMT+7]
Three first volunteers received the first shot of a dose of 50mcg of Nanocovax Covid-19 vaccine on December 26 morning.
One of the three first volunteers receiving first shots of 50mcg dose of Covid-19 vaccine (Photo: VNA)
Developed by the Nanogen Pharmaceutical Biotechnology JSC and the Vietnam Military Medical University, Nanocovax is Vietnam s first Covid-19 candidate vaccine to reach the human trial stage.
A total of 60 volunteers, aged 18-50, were selected for the first phase of the clinical trials. They are divided into three groups for receiving three doses of 25 mcg, 50 mcg and 75 mcg, respectively. The vaccination consists of two injections 28 days apart.